Jiang Zhao-Yan, Cai Qu, Chen Er-Zhen
Department of Surgery, Shanghai Institute of Digestive Surgery, Shanghai, China.
Department of Emergency, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
PLoS One. 2014 Jan 30;9(1):e87200. doi: 10.1371/journal.pone.0087200. eCollection 2014.
In this study, we evaluated the association between these polymorphisms and gallstone disease using meta-analysis and compared the hepatic ABCG5/G8 mRNA expression and biliary lipids composition in patients with different genotypes of T400K and Y54C.
Data were analyzed using the Stata/SE 11.0 software and a random- effects model was applied irrespective of between-study heterogeneity. Hepatic mRNA expression of ABCG5/G8 genes in 182 patients with gallstone disease and 35 gallstone-free patients who underwent cholecystectomy were determined using real-time PCR. Genotypes of Y54C and T400K in the ABCG8 gene were determined by allelic discrimination using either genomic DNA or hepatic cDNA as template by Taqman assays. Biliary compostion in gallbladder bile was assayed in these patients as well.
Ten papers including 13 cohorts were included for the final analysis. In the genotype model, the overall association between genotype with gallstone was significant for D19H (OR = 2.43, 95%CI: 2.23-2.64, P<0.001), and for Y54C (OR = 1.36, 95%CI: 1.01-1.83, P = 0.044), or T400K (OR = 1.17, 95%CI: 0.96-1.43. P = 0.110). In allele model, minor alleles of D19H polymorphism (allele D: OR = 2.25, 95%CI: 2.10-2.42, P<0.001) and of T400K polymorphism (allele K: OR = 1.18, 95%CI: 1.06-1.31, P<0.001) were related with an increased risk of gallstone disease. However, minor allele of Y54C polymorphism (allele Y, OR = 1.08, 95%CI: 0.96-1.21, P = 0.146) was not related with gallstone disease. I(2) statistics indicated no significant between-study heterogeneity for all genetic models for any of the three polymorphisms. Funnel plot and Egger's test suggested the absence of publication bias as well. However, no association of T400K and Y54C polymorphism with hepatic ABCG8/G5 mRNA expression or biliary lipids composition was found.
Our study showed strong association of D19H polymorphism with gallstone disease. T400K and Y54C polymorphism, though to a less extent, may also relate with gallstone disease.
在本研究中,我们采用荟萃分析评估了这些多态性与胆结石疾病之间的关联,并比较了不同T400K和Y54C基因型患者的肝脏ABCG5/G8 mRNA表达及胆汁脂质成分。
使用Stata/SE 11.0软件进行数据分析,无论研究间的异质性如何,均应用随机效应模型。采用实时PCR法测定182例胆结石疾病患者和35例接受胆囊切除术的无胆结石患者肝脏中ABCG5/G8基因的mRNA表达。通过Taqman分析,以基因组DNA或肝脏cDNA为模板,通过等位基因鉴别法确定ABCG8基因中Y54C和T400K的基因型。同时也对这些患者胆囊胆汁中的胆汁成分进行了检测。
最终分析纳入了10篇论文,包括13个队列。在基因型模型中,D19H(比值比[OR]=2.43,95%置信区间[CI]:2.23 - 2.64,P<0.001)、Y54C(OR=1.36,95%CI:1.01 - 1.83,P=0.044)或T400K(OR=1.17,95%CI:0.96 - 1.43,P=0.110)的基因型与胆结石之间的总体关联具有统计学意义。在等位基因模型中,D19H多态性的次要等位基因(等位基因D:OR=2.25,95%CI:2.10 - 2.42,P<0.001)和T400K多态性的次要等位基因(等位基因K:OR=1.18,95%CI:1.06 - 1.31,P<0.001)与胆结石疾病风险增加相关。然而,Y54C多态性的次要等位基因(等位基因Y,OR=1.08,95%CI:0.96 - 1.21,P=0.146)与胆结石疾病无关。I²统计量表明,这三种多态性的所有遗传模型在研究间均无显著异质性。漏斗图和Egger检验也表明不存在发表偏倚。然而,未发现T400K和Y54C多态性与肝脏ABCG8/G5 mRNA表达或胆汁脂质成分之间存在关联。
我们的研究表明D19H多态性与胆结石疾病密切相关。T400K和Y54C多态性虽然相关性较弱,但也可能与胆结石疾病有关。